Sanofi India Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate

Pursuant to the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the the Board of Directors at its meeting held today i.e., 3rd November 2022 noted the resignation of Mr. Charles Billard and based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Ms. Annapurna Das (DlN: 08634664) as an Additional and Non-Executive (Non-Independent) Director of the Company with effect from 3rd November 2022. The said appointment will be subject to the approval of the Members of the Company through Postal Ballot.